Page 94 - SGH PR REPORT - FEBRUARY 2025

2/19/25, 11:53 AM Saudi German Health and BD Company sign MoU to revolutionise microbiology diagnostics
The partnership aims to address existing challenges in microbiology by providing rapid and precise
diagnostic solutions, thus establishing new standards for healthcare efficiency. The launch of these
innovative lab devices will allow SGH to provide quicker, more accurate diagnoses, enhancing patient
outcomes and elevating the quality of healthcare throughout the region.

Makarem Sobhi Batterjee, Vice Chairman of Saudi German Health, stated: “We are proud to partner with
BD Company to introduce these advanced diagnostic devices to our laboratory. The deployment of
these advanced lab devices marks a significant milestone in our ongoing commitment to providing the
highest level of patient care. More importantly, the goals of this collaboration align seamlessly with our

brand ethos of ‘Caring Like Family,’ and we are excited to integrate these innovations into our
processes.”

This partnership offers several key benefits. The MALDI-TOF device uses advanced technology to
quickly and accurately detect a wide range of pathogens, including those that are difficult to culture,
dramatically improving diagnostic accuracy and speed. By identifying the specific microorganisms

responsible for infections, MALDI-TOF ensures the selection of the most effective antibiotics, mitigating
the overuse of broad-spectrum antibiotics and combating antibiotic resistance.

This partnership is expected to benefit more than 2 million patients annually, allowing the healthcare
provider to deliver quicker, more accurate diagnostics and enhance patient outcomes. The agreement

aims to streamline microbiology diagnostic processes, reducing turnaround times and ensuring timely
treatment for patients. With faster and more precise diagnoses, the collaboration is set to elevate the
overall healthcare experience, providing significant advantages to both patients and healthcare
providers.

Philippe Villard, Senior Director of Commercial Operations, EMEA at BD Company, stated: “We are

excited to collaborate with Saudi German Health on this innovative initiative. The rollout of our advanced
diagnostic solutions will significantly benefit healthcare providers by improving diagnostic accuracy and
efficiency. Technologies like MALDI-TOF have demonstrated their effectiveness in enhancing diagnostic

outcomes in other regions, and we believe this collaboration will yield similar results in the Kingdom of
Saudi Arabia.”

The rapid diagnostic solutions introduced by BD and SGH are expected to become a model for
healthcare providers across the region. This partnership will usher in an era of faster, more accurate
diagnoses and improved patient care by refining diagnostic accuracy and streamlining processes. This

partnership will significantly enhance the social and economic value of the local healthcare system,
contributing to the overall well-being of the community.

-Ends-

https://www.zawya.com/en/press-release/companies-news/saudi-german-health-and-bd-company-sign-mou-to-revolutionise-microbiology-diagnostics-… 2/3